13 November 2019
  • Comunicació i cultura científica
  • Càncer
  • Medicina Regenerativa
  • Neurociències
  • Medicina Translacional

Here comes Sinergia, the festival of research and innovation in health of L'Hospitalet

Under the name of Sinergia, the Bellvitge Biomedical Research Institute (IDIBELL), the Bellvitge University Hospital, the Catalan Institute of Oncology and the Bellvitge Medicine and Health Sciences Campus of the University of Barcelona will showcase the innovative research that they carry out du

12 November 2019
  • Promoció

Innovation for value analyzes the use of big data and the new power it gives to patients

The conference on health innovation Innovation for value, held on November 8 in Barcelona, ​​has analyzed the opportunities offered by technological advances in the field of health.

05 November 2019

Bellvitge begins telemedicine monitoring of patients with chronic heart failure

The Bellvitge University Hospital and the Bellvitge Biomedical Research Institute (IDIBELL) have begun a telemedicine monitoring project for patients with chronic heart failure within the framework of the HERMeS clinical trial, in which 10 centers in Spain will participate.

30 October 2019

NIH infoday

  • Convocatòries competitives

Successful informative session on U.S. Non-dilutive funding at IDIBELL

The “U.S. Federal sources for health Projects” informative session was successfully held at IDIBELL last October 21st. Jointly co-organized with AGAUR, the Agency for Management of University and Research Grants, the session featured two seminars on U.S.

28 October 2019
  • Càncer

Scientists discover the implication of a new protein involved in liver cancer

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have just described for the first time the crucial involvement of a cell membrane protein in the development and progression of liver cancer, according to an article published in the Journal of Hepatology.